The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users
about
Public health and international drug policy.A Smartphone Application Supporting Recovery from Heroin Addiction: Perspectives of Patients and Providers in China, Taiwan, and the USASocial-structural factors influencing periods of injection cessation among marginalized youth who inject drugs in Vancouver, Canada: an ethno-epidemiological study.Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada.Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs: State of Research and Future Directions.Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concernA longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugsCommentary on Nolan et al. (2014): Opiate substitution treatment and hepatitis C virus prevention: building an evidence base?Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.Direct-acting antiviral agents for HCV infection affecting people who inject drugs.Utilization of buprenorphine and methadone among opioid users who inject drugs.Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.Scaling up HCV prevention and treatment interventions in rural USA - model projections for tackling an increasing epidemic.HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study.The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs.Outcomes of Patients in Long-Term Opioid Maintenance Treatment.Needle syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach.Daily alcohol use as an independent risk factor for HIV seroconversion among people who inject drugs.HIV And HCV infection among opiate-dependent patients and methadone doses: the PROTEUS study.Commentary on Enns et al. (2016): Supervised injection facilities as a cost-effective intervention.HCV reinfection incidence among individuals treated for recent infection.A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients.HIV treatment as prevention among people who inject drugs - a re-evaluation of the evidence.Hepatitis C elimination by 2030 through treatment and prevention: think global, act in local networks.'Crisis' and 'everyday' initiators: A qualitative study of coercion and agency in the context of methadone maintenance treatment initiation.Substance Use Patterns of HIV-Infected Russian Women with and Without Hepatitis C Virus Co-infection.Recommendations for the management of hepatitis C virus infection among people who inject drugs.Commentary on Zhou et al. (2015): Research on methadone maintenance treatment (MMT) as prevention for HCV infection--MMT is not a single variable.Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy.Importance and Contribution of Community, Social, and Healthcare Risk Factors for Hepatitis C Infection in Pakistan.Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting.Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 CollaborationImpact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?
P2860
Q30377895-12429FBD-20BB-4EAE-93E7-15BDA83C3192Q33447050-A7731D2F-B836-4343-B05C-5716C13A1C65Q33768352-52CACB38-B1DC-4951-BA18-14C7385CEBCEQ35581138-8F13CF03-B781-4E41-9BB2-F9F159462430Q35703205-9DCF5393-522E-41CA-ACEB-D01505843029Q35817533-E4B982CD-AA3B-4B08-ABEF-C48DEB1400CFQ35823557-38338DCC-2AB2-4E3C-A0F6-114CC2D2FFAFQ35889562-28663D49-2430-4AFE-8000-07C448E30260Q35903698-32BFFE06-1E6B-4419-98D0-D19F2879267DQ35998417-D8A59718-2393-480B-B591-B8B362AA42D8Q36090175-ADBED708-1176-4A29-9B10-6CF4062BA1CAQ38613271-1171EF4F-D664-476F-9E72-BC98C3C623FDQ38630550-F2184AEB-FD31-4F24-9172-9D7658431B1AQ38661825-F6CCEB09-ABC1-4B0D-8D0C-C776A792A879Q38666907-3E96837F-5D6D-4B0B-9E53-E6B88EB05ADDQ38692113-CBD94E9A-1991-48D0-AFBF-BC94F79B6800Q38931620-29E7E4C1-83B1-470C-968A-178BC1F981A5Q39123236-85371E95-BA8F-4779-BA91-842662494F68Q39646487-5F46DBC6-91E4-4F09-B8F1-2E2AF9E577D5Q40048259-FA731661-EF4B-4D3F-AC9C-361AB5CE9B72Q40092669-F19B192B-A333-4071-913B-D29C298FD0B5Q40118634-6C228443-A0BB-48AE-A035-B65332CF5793Q40240525-F514D71C-CB7C-41D3-B520-96A57038BE95Q40250921-AE5481A8-5641-46C1-83DF-3D8A3873DFB6Q40351462-A9797FC4-BB1E-410C-B259-6FA63B59E825Q40393982-0248EF65-62A5-4D7B-A5B1-55BC90688BF3Q40582450-A30C0B42-9398-45F1-8CE0-00DD80B142E8Q40622144-9F601609-1B74-4F4A-AA0C-8ECC11E497B2Q40637053-65A04198-3C72-4581-9F41-D609DC464C8BQ40694556-1D20C025-7727-415F-871B-E344E6713E06Q40748586-9CF60D53-0C6F-449B-B7BD-2E1B429AFADEQ41047662-278DD8F6-0B97-434B-9675-BD9852B7EA7EQ41338757-C9ACF80F-711A-42C2-BEB0-445D6D58A590Q42720607-F9D1EF90-D057-4476-A132-778A4AB4DA52Q45323809-240F614C-2E39-457B-99C9-E66A8E7F365BQ47579352-C2DDBD6F-DFBC-45E1-AD55-950C61C4AC5FQ48096212-3F3B5C35-27B3-4A67-B621-E71308A03671Q56556912-9EC3907A-0DCD-4E33-81D3-20E990987A5FQ57700826-73A7D88E-D06D-4A3F-B938-38389A75BE41
P2860
The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The impact of methadone mainte ...... dence among illicit drug users
@ast
The impact of methadone mainte ...... dence among illicit drug users
@en
The impact of methadone mainte ...... dence among illicit drug users
@nl
type
label
The impact of methadone mainte ...... dence among illicit drug users
@ast
The impact of methadone mainte ...... dence among illicit drug users
@en
The impact of methadone mainte ...... dence among illicit drug users
@nl
prefLabel
The impact of methadone mainte ...... dence among illicit drug users
@ast
The impact of methadone mainte ...... dence among illicit drug users
@en
The impact of methadone mainte ...... dence among illicit drug users
@nl
P2093
P2860
P50
P356
P1433
P1476
The impact of methadone mainte ...... dence among illicit drug users
@en
P2093
Jason Grebely
Nadia Fairbairn
Seonaid Nolan
Viviane Dias Lima
P2860
P304
P356
10.1111/ADD.12682
P407
P577
2014-08-14T00:00:00Z